دراسة فسلجية وكيموحيوية ونسيجية لمرضى ابيضاض الدم اللمفاوي الحاد غير الوراثي في محافظة كربلاء المقدسة
Author name:
همام علي هادي
Supervisor name:
ستار جاسم حتروش | رشا حسن جاسم
Abstract:
The rate of cancer infection has increased with a clear rise in the incidence of leukemia in Iraq's common diseases in 2017, which was the seventh place in 1989, as follows. Generally, about 10 among 100,000 people are infected with leukemia, male have the biggest ratio between the patients with leukemia, finally, Acute Lymphocytic Leukemia is increased at patients with 3 to 7 years old. During the period from the beginning of February 2016 to the first week of 2017 in the Center of Oncology of Hematology in the medical city of Hussein in Karbala', 30 patients with acute lymphocytic leukemia their age were ranged from 2 - 13 years old (19 male and 11 female), without familiar history with cancerous disease. The samples were collected before treatment with chemotherapy, and they were follow - up during the stages of treatment. The control group included 30 samples ranging from 1 - 13 years (18 males and 12 females) Numerous biochemical and histological parameters were assessed in the samples of study patients before and after receiving treatment and the recorded results were compared to the control group. The results of the study showed significant results (p<0.05) at the levels of CLEC4E, MDA, Ceruloplasmin Oxidase Concentration and EOP in the group of animals with acute lymphocytic leukemia before receiving treatment compared to healthy individuals. The current study showed decreased concentrations of CLEC4E, Ceruloplasmin Oxidase Concentration, Ceruloplasmin Oxidase Concentration and Ceruloplasmin Oxidase Activity, while EOP levels increased after chemotherapy, while MDA remained at an unrecognized level at diagnosis. The study showed significant differences (p=0.000) when elevating a number of blood parameters, WBC level and Ferritin concentration. When the stud recorded statistically significant rise in the level of platelets and Hb concentration before chemotherapy. At diagnosis, the present study showed a significant difference (p<0.05) in Fe, Cu, Zn and Ni levels in the patients group, before treatment. However, statistical analysis of trace elements in the sera of patients after treatment didn’t show significant differ than their levels at diagnosis. The study the effect of acute lymphocytic leukemia in the function of kidney showed significant increase in the levels of ANP and Urea in sera of patient samples as well as levels of urinary microalbumin comparison to control group levels, contrast to that, Creatinin levels showed significant (p=0.001) decrease in serum of patients group. Comparative study showed that there were statistically significant differences (p=0.000) of ANP, Urea, Creatinin, Uric Acid, and Microalbumin in patients with acute lymphocytic leukemia after receiving chemotherapy compared to healthy peers.In order to evaluate liver function, GOT and GPT levels as well as STP levels in patients with leukemia were observed within the range recorded in healthy individuals. On the other hand, the current study showed a rise in the levels of ALP enzyme in patients exceeded twice that recorded in the group of healthy children. After receiving chemotherapy, the study showed a significant increase (p=0.000) for GOT, GPT and ALP levels for the group of patients compared to healthy individuals, a significant decrease (p=0.000) of STP levels in the group of patients compared to healthy patients. The study identified many differences between patients and healthy males as well as between infected and healthy females at the level of implicit comparisons between the two groups at diagnosis and after treatment, as shown in the table below which summarizes the relationship between patients of both ganders with their healthy peers. The current study showed statistically significant statistically associations, the clearest among them was recorded when CLEC4E correlated to EOP, which were positive in 100% of the study samples at diagnosis and negative in the same samples after receiving chemotherapy. The results of the study showed that 80% of children with acute lymphocytic leukemia were with type 1, L1, 17% of type 2, L2 and 3% of the third type L3, the promise of the first type has a good outcome of the disease as the response is good for treatment and go through recovery after treatment.
